+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

From
From
From
From
From
From
PD-1 Resistant Head and Neck Cancer Market Report 2025 - Product Thumbnail Image

PD-1 Resistant Head and Neck Cancer Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Malignant Mesothelioma Market Report 2025 - Product Thumbnail Image

Malignant Mesothelioma Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
From
Cancer Supportive Care Drugs Market Report 2025 - Product Thumbnail Image

Cancer Supportive Care Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Head and Neck Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Oncolytic Virus Therapy Market Report 2025 - Product Thumbnail Image

Oncolytic Virus Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hepatocellular Carcinoma Drugs Market Report 2025 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Sarcoma Drugs Market Report 2025 - Product Thumbnail Image

Sarcoma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2025 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Solid Tumor Cancer Treatment Market Report 2025 - Product Thumbnail Image

Solid Tumor Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Cancer Immunotherapy Market Report 2025 - Product Thumbnail Image

Cancer Immunotherapy Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more